Title : Cisplatin-resistant bladder carcinoma cells: enhanced expression of metallothioneins.

Pub. Date : 1999 Jun

PMID : 10422815






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 On the protein level, the cisplatin-resistant cells reveal an enhanced expression of metallothionein II (MTII), but not MTI, suggesting that the cisplatin resistance we observed in these sublines is at least partly mediated by MTII. Cisplatin metallothionein-2 Bos taurus
2 On the protein level, the cisplatin-resistant cells reveal an enhanced expression of metallothionein II (MTII), but not MTI, suggesting that the cisplatin resistance we observed in these sublines is at least partly mediated by MTII. Cisplatin metallothionein-2 Bos taurus
3 On the protein level, the cisplatin-resistant cells reveal an enhanced expression of metallothionein II (MTII), but not MTI, suggesting that the cisplatin resistance we observed in these sublines is at least partly mediated by MTII. Cisplatin metallothionein-2 Bos taurus
4 On the protein level, the cisplatin-resistant cells reveal an enhanced expression of metallothionein II (MTII), but not MTI, suggesting that the cisplatin resistance we observed in these sublines is at least partly mediated by MTII. Cisplatin metallothionein-2 Bos taurus
5 On the protein level, the cisplatin-resistant cells reveal an enhanced expression of metallothionein II (MTII), but not MTI, suggesting that the cisplatin resistance we observed in these sublines is at least partly mediated by MTII. Cisplatin metallothionein-2 Bos taurus
6 On the protein level, the cisplatin-resistant cells reveal an enhanced expression of metallothionein II (MTII), but not MTI, suggesting that the cisplatin resistance we observed in these sublines is at least partly mediated by MTII. Cisplatin metallothionein-2 Bos taurus